Compare with Orchid Chemicals - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALKEM LABORATORIES vs ORCHID PHARMA LTD - Comparison Results

ORCHID PHARMA LTD 
   Change

Orchid Chemicals & Pharmaceuticals Ltd. (Orchid) is today a globally recognized, integrated pharmaceutical company with core competencies in the development and manufacture of Active Pharmaceutical Ingredients (APIs) and Finished Dosage Forms as well... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ALKEM LABORATORIES ORCHID PHARMA LTD ALKEM LABORATORIES/
ORCHID PHARMA LTD
 
P/E (TTM) x - -0.5 - View Chart
P/BV x 7.2 0.1 6,125.0% View Chart
Dividend Yield % 0.6 0.0 -  

Financials

 ALKEM LABORATORIES   ORCHID PHARMA LTD
EQUITY SHARE DATA
    ALKEM LABORATORIES
Mar-16
ORCHID PHARMA LTD
Sep-13
ALKEM LABORATORIES/
ORCHID PHARMA LTD
5-Yr Chart
Click to enlarge
High Rs1,589194 819.1%   
Low Rs1,23235 3,520.0%   
Sales per share (Unadj.) Rs417.5276.5 151.0%  
Earnings per share (Unadj.) Rs56.3-79.2 -71.1%  
Cash flow per share (Unadj.) Rs64.7-43.5 -148.9%  
Dividends per share (Unadj.) Rs12.700-  
Dividend yield (eoy) %0.90-  
Book value per share (Unadj.) Rs292.953.9 543.1%  
Shares outstanding (eoy) m119.5770.45 169.7%   
Bonus/Rights/Conversions -ESOP-  
Price / Sales ratio x3.40.4 815.8%   
Avg P/E ratio x25.1-1.4 -1,733.3%  
P/CF ratio (eoy) x21.8-2.6 -827.2%  
Price / Book Value ratio x4.82.1 226.8%  
Dividend payout %22.60-   
Avg Mkt Cap Rs m168,6538,067 2,090.8%   
No. of employees `000NA2.8 0.0%   
Total wages/salary Rs m9,1712,527 362.9%   
Avg. sales/employee Rs ThNM6,956.1-  
Avg. wages/employee Rs ThNM902.5-  
Avg. net profit/employee Rs ThNM-1,993.0-  
INCOME DATA
Net Sales Rs m49,91519,477 256.3%  
Other income Rs m1,645407 404.0%   
Total revenues Rs m51,56119,884 259.3%   
Gross profit Rs m8,4821,103 769.3%  
Depreciation Rs m1,0062,519 39.9%   
Interest Rs m6715,227 12.8%   
Profit before tax Rs m8,451-6,236 -135.5%   
Minority Interest Rs m-11420 -577.7%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0511 0.0%   
Tax Rs m1,606-125 -1,282.7%   
Profit after tax Rs m6,731-5,580 -120.6%  
Gross profit margin %17.05.7 300.2%  
Effective tax rate %19.02.0 946.6%   
Net profit margin %13.5-28.7 -47.1%  
BALANCE SHEET DATA
Current assets Rs m27,06211,014 245.7%   
Current liabilities Rs m15,32432,060 47.8%   
Net working cap to sales %23.5-108.1 -21.8%  
Current ratio x1.80.3 514.1%  
Inventory Days Days6795 70.1%  
Debtors Days Days4134 123.0%  
Net fixed assets Rs m12,61029,440 42.8%   
Share capital Rs m239705 33.9%   
"Free" reserves Rs m34,4902,043 1,688.5%   
Net worth Rs m35,0273,800 921.8%   
Long term debt Rs m1,2129,018 13.4%   
Total assets Rs m54,38746,510 116.9%  
Interest coverage x13.6-0.2 -7,043.4%   
Debt to equity ratio x02.4 1.5%  
Sales to assets ratio x0.90.4 219.2%   
Return on assets %13.6-0.8 -1,790.6%  
Return on equity %19.2-146.9 -13.1%  
Return on capital %24.9-3.7 -665.6%  
Exports to sales %12.937.9 34.2%   
Imports to sales %3.122.6 13.6%   
Exports (fob) Rs m6,4617,378 87.6%   
Imports (cif) Rs m1,5404,406 35.0%   
Fx inflow Rs m6,5637,513 87.4%   
Fx outflow Rs m3,0125,649 53.3%   
Net fx Rs m3,5521,865 190.5%   
CASH FLOW
From Operations Rs m7,2591,682 431.6%  
From Investments Rs m1,864-9,860 -18.9%  
From Financial Activity Rs m-9,2736,644 -139.6%  
Net Cashflow Rs m-150-1,535 9.8%  

Share Holding

Indian Promoters % 66.9 32.3 207.1%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 33.1 4.6 719.6%  
FIIs % 0.0 3.3 -  
ADR/GDR % 0.0 4.6 -  
Free float % 0.0 55.3 -  
Shareholders   68,381 84,811 80.6%  
Pledged promoter(s) holding % 0.0 54.9 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ALKEM LABORATORIES With:   CIPLA  PIRAMAL ENTERPRISES  NATCO PHARMA  SUN PHARMA  PFIZER  

Compare ALKEM LABORATORIES With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

CSB Bank IPO, October Passenger Vehicle Sales, and Top Cues in Focus Today(Pre-Open)

On Tuesday, Indian share markets witnessed buying interest during closing hours and ended on a positive note.

Related Views on News

ORCHID PHARMA LTD Announces Quarterly Results (2QFY19); Net Profit Up 67.1% (Quarterly Result Update)

Jan 31, 2019 | Updated on Jan 31, 2019

For the quarter ended September 2018, ORCHID PHARMA LTD has posted a net profit of Rs 231 m (up 67.1% YoY). Sales on the other hand came in at Rs 1 bn (down 31.9% YoY). Read on for a complete analysis of ORCHID PHARMA LTD's quarterly results.

ORCHID PHARMA LTD Announces Quarterly Results (4QFY18); Net Profit Up 50.8% (Quarterly Result Update)

Aug 24, 2018 | Updated on Aug 24, 2018

For the quarter ended March 2018, ORCHID PHARMA LTD has posted a net profit of Rs 924 m (up 50.8% YoY). Sales on the other hand came in at Rs 2 bn (down 24.0% YoY). Read on for a complete analysis of ORCHID PHARMA LTD's quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

More Views on News

Most Popular

Crash Alert! Is There a Big Bubble in Nestle, HUL and Asian Paints?(Profit Hunter)

Nov 7, 2019

Is this the beginning of the end of multibagger gains in quality stocks like Nestle, HUL, and Asian Paints?

The Smartest Stock to Buy for 2020(Profit Hunter)

Nov 14, 2019

Small-cap stocks are selling at bargain prices today and are poised to generate a lot of wealth in 2020 and beyond...

Why Moody's Rating Downgrade is a Strong Sign to Buy Stocks(The 5 Minute Wrapup)

Nov 8, 2019

Investors who took cues from Moody's rating downgrade in 1992 and 2002 created some of the biggest wealth of their lifetime.

A Trade that Could Generate Profits for Decades

Nov 14, 2019

India's #1 trader is back on the Investor Hour. Vijay Bhambwani talks to us about his super-profitable trading system and shares with us his #1 long term trade. Listen in...

The One Trade I'm Most Bullish on Now

Nov 12, 2019

A highly specific trade to potentially triple your money in just three months. You won't find this information anywhere else!

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

ALKEM LABORATORIES SHARE PRICE


Nov 19, 2019 (Close)

TRACK ALKEM LABORATORIES

  • Track your investment in ALKEM LABORATORIES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ALKEM LABORATORIES

ALKEM LABORATORIES 5-YR ANALYSIS

COMPARE ALKEM LABORATORIES WITH

MARKET STATS